The DOI matches its Crossref record.
Permeation enhancer effect of chitosan and chitosan derivatives: Comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells
Open accessAbstract
In this study four quaternized derivatives of chitosan: trimethyl chitosan (TMC), dimethylethyl chitosan (DMEC), diethylmethyl chitosan (DEMC) and triethyl chitosan (TEC) with degree of substitution of approximately 50+/-5% were synthesized and their effect on the permeability of insulin across intestinal Caco-2 monolayers was studied and compared with chitosan both in free-soluble form and in nanoparticulate systems. Transepithelial electrical resistance (TEER) studies revealed that all four chitosan derivatives in free-soluble forms were able to decrease the TEER value in the following order TMC>DMEC>DEMC=TEC>chitosan, indicating their abilities to open the tight junctions. Recovery studies on the TEER showed that the effect of the polymers on Caco-2 cell monolayer is reversible and proves the viability of cells after incubation with all polymers. A similar rank order was also observed when measuring the zeta-potentials of the various polymers in solution form. Transport studies of insulin together with the soluble polymers across Caco-2 cell layers showed the following ranking: TMC>DMEC>DEMC>TEC>chitosan which is in agreement with the strength of the cationic charge of the polymer. In comparison to the free-soluble polymers, the nanoparticles prepared by ionic gelation of the chitosan and its quaternized derivatives had much lower effect on decreasing the TEER by opening of the tight junctions. This can be explained by the reduced available amount of positive charge at the surface of the nanoparticles. In accordance with these results, the insulin loaded nanoparticles showed much less permeation across the Caco-2 cell monolayer in comparison to the free-soluble polymers. Mass balance transport studies revealed that a substantial amount of the nanoparticles has been entrapped into the Caco-2 monolayer or attached to the cell surface. It can thus be stated that while free-soluble polymers can reversibly open the tight junctions and increase the permeation of insulin, the nanoparticles had basically only a low effect on the opening of the tight junction and the paracellular transport of insulin across the Caco-2 cell monolayer. These data convincingly show that nanoparticles consisting of chitosan and its quaternary ammonium derivatives loaded with insulin are less effective in facilitating paracellular transport across Caco-2 cell monolayers than the corresponding free polymers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
Mohammed, M., Syeda, J., Wasan, K., & Wasan, E. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9040053 · Cited by 1,362
Nanoparticles for direct nose-to-brain delivery of drugs
Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734
Chitosan Nanoparticles: A Promising System in Novel Drug Delivery
Nagpal, K., Singh, S. K., & Mishra, D. N. (2010) · CHEMICAL & PHARMACEUTICAL BULLETIN · doi:10.1248/cpb.58.1423 · Cited by 660
Chitosan-based delivery systems for protein therapeutics and antigens
Amidi, M., Mastrobattista, E., Jiskoot, W., & Hennink, W. E. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.009 · Cited by 620
Harugade, A., Sherje, A. P., & Pethe, A. (2023) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2023.105634 · Cited by 474
Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules
Chen, M.-C., Mi, F.-L., Liao, Z.-X., Hsiao, C.-W., Sonaje, K., Chung, M.-F., Hsu, L.-W., & Sung, H.-W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.010 · Cited by 451
Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps
Bergin, I. L., & Witzmann, F. A. (2013) · International Journal of Biomedical Nanoscience and Nanotechnology · doi:10.1504/ijbnn.2013.054515 · Cited by 412
Biocompatibility of Chitosan Carriers with Application in Drug Delivery
Rodrigues, S., Dionísio, M., López, C. R., & Grenha, A. (2012) · Journal of Functional Biomaterials · doi:10.3390/jfb3030615 · Cited by 389
A review: using nanoparticles to enhance absorption and bioavailability of phenolic phytochemicals
Li, Z., Jiang, H., Xu, C., & Gu, L. (2015) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2014.05.010 · Cited by 376
Chitosan-based nanostructures: A delivery platform for ocular therapeutics
de la Fuente, M., Raviña, M., Paolicelli, P., Sanchez, A., Seijo, B., & Alonso, M. J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.026 · Cited by 354
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 324
Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action
Adhikari, H. S., & Yadav, P. N. (2018) · International Journal of Biomaterials · doi:10.1155/2018/2952085 · Cited by 313
Jin, Y., Song, Y., Zhu, X., Zhou, D., Chen, C., Zhang, Z., & Huang, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.075 · Cited by 301
Chitosan-based Colloidal Polyelectrolyte Complexes for Drug Delivery: A Review
Wu, D., Zhu, L., Li, Y., Zhang, X., Xu, S., Yang, G., & Delair, T. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116126 · Cited by 288
Rational Design of Nanocarriers for Intracellular Protein Delivery
Qin, X., Yu, C., Wei, J., Li, L., Zhang, C., Wu, Q., Liu, J., Yao, S. Q., & Huang, W. (2019) · Advanced Materials · doi:10.1002/adma.201902791 · Cited by 280
Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solution
Vllasaliu, D., Exposito-Harris, R., Heras, A., Casettari, L., Garnett, M., Illum, L., & Stolnik, S. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.020 · Cited by 252
Drug delivery to inflamed colon by nanoparticles: Comparison of different strategies
Coco, R., Plapied, L., Pourcelle, V., Jérôme, C., Brayden, D. J., Schneider, Y.-J., & Préat, V. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.017 · Cited by 162
Oral delivery of peptides and proteins using lipid-based drug delivery systems
Li, P., Nielsen, H. M., & Müllertz, A. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.717068 · Cited by 116
“The paracellular pathway, which comprises aqueous channels for molecular diffusion between enterocytes, may be a dominant pathway for hydrophilic peptides and proteins [25], yet the aqueous channels have been estimated to have a pore radius of around 0.”
BackgroundMu, Y., Fu, Y., Li, J., Yu, X., Li, Y., Wang, Y., Wu, X., Zhang, K., Kong, M., Feng, C., et al. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.09.020 · Cited by 113
Metadata
- Authors
- SADEGHI, A., DORKOOSH, F., AVADI, M., WEINHOLD, M., BAYAT, A., DELIE, F., GURNY, R., LARIJANI, B., RAFIEETEHRANI, M., & JUNGINGER, H.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 70
- Issue
- 1
- Pages
- 270-278
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2049701856
- Cited by
- 223
- References
- 0
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.